calanolide a has been researched along with rifampin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bavishi, A; Dodia, N; Manvar, A; Patel, J; Radadiya, A; Rawal, K; Shah, A; Vora, V | 1 |
| Brickner, SJ; Gold, B; Guo, X; Little, D; Liu, G; Lu, S; Nathan, CF; Pingle, M; Roberts, J; Somersan-Karakaya, S; Warrier, T; Zheng, P | 1 |
| Barrow, E; Barrow, WW; Flavin, MT; Lin, YM; Suling, WJ; Westbrook, L; Xu, ZQ | 1 |
3 other study(ies) available for calanolide a and rifampin
| Article | Year |
|---|---|
Diversity oriented design of various hydrazides and their in vitro evaluation against Mycobacterium tuberculosis H37Rv strains.
Topics: Anti-Bacterial Agents; Drug Design; Hydrazines; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Stereoisomerism; Structure-Activity Relationship | 2011 |
Synthetic calanolides with bactericidal activity against replicating and nonreplicating Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyranocoumarins; Structure-Activity Relationship | 2014 |
Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.
Topics: Animals; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Cell Line; Chlorocebus aethiops; Cisplatin; Coumarins; DNA; Drug Resistance, Bacterial; Ifosfamide; Inhibitory Concentration 50; Macrophages; Microbial Sensitivity Tests; Mitomycin; Mycobacterium tuberculosis; Pyranocoumarins; Rifampin; RNA; Vero Cells; Virus Replication | 2004 |